Chemotherapy regimen (N) | WEnCA (N) | Relapse | No relapse | P-value |
---|---|---|---|---|
 | N = 42 (%) | N = 46 (%) |  | |
FOLFOX-4 plus Cetuximab (N = 59) | Positive (N = 8) | 6 (75) | 2 (25) | 0.047 |
 | Negative (N = 51) | 17 (33.3) | 34 (66.7) |  |
FOLFOX-4 (N = 29) | Positive (N = 6) | 3 (50) | 3 (50) | 0.633 |
 | Negative (N = 23) | 16 (48.5) | 7 (21.2) |  |